Sunscreen — Technical Specification Overview

Key Technical Parameters #

Sourcing the right UV filter system starts long before formulation — it starts at the raw material specification stage. Brand partners who brief us on SPF products typically focus on the finished formula: SPF value, aesthetics, market claims. What they rarely ask about upfront is filter grade selection, purity thresholds, and the incoming quality criteria that determine whether a batch holds together at 500 kg or falls apart at 8 weeks stability. This article focuses on that upstream layer: how key UV filter grades compare across purity, photostability, solubility, and regulatory status, and how those parameters translate into real formulation decisions on our production line. Brand developers who care about stability, label compliance, and reproducibility batch-to-batch will find this useful.

The Real Selection Criteria — Not What’s on the Datasheet #

Most buyer conversations start with INCI name and price. Both matter, but neither predicts formulation outcome on its own.

What actually determines whether a UV filter performs is purity consistency across lots, melting point reproducibility (especially for oil-phase filters), photostability under real-UV exposure, and compatibility with the emulsion architecture you’re building. A filter that looks identical across two supplier datasheets can behave completely differently in a water-in-silicone base versus a conventional O/W emulsion.

We track incoming lot variation under our QC-F03 UV Raw Material Inspection protocol. Over 18 months of incoming lots across our primary filter range, purity drift was the most common non-conformance — not the number reported, but its consistency lot-to-lot. That variability is what causes batch-to-batch SPF drift, not the formula.

Price matters at scale. Purity consistency matters more.

Head-to-Head Comparison — UV Filter Grades Across Key Parameters #

The table below covers five commonly specified UV filters across parameters that directly affect formulation decisions. These are not marketing tiers — they’re the criteria our lab uses when qualifying a new supplier or switching grades.

Caption: Comparative specification data for five commonly used UV filters. EU maximum concentrations per EU Cosmetics Regulation 1223/2009, Annex VI. Photostability ratings reflect internal assessment under our QC-F03 protocol; supplier CoA data and in-house accelerated photodegradation results may differ.

The pattern in this table isn’t subtle. Photostability and solubility profile are usually inversely correlated with ease of formulation. The filters with the best photostability — Tinosorb S, Tinosorb M, ZnO — all require more processing effort: pre-dispersion, milling, or viscosity management. Octinoxate is the easiest to work with at bench scale and the most problematic at 8-week stability under sunlight exposure.

For a brand targeting the EU and US simultaneously, the filter selection calculus shifts considerably. Tinosorb S and Tinosorb M are not approved under the FDA Cosmetics Guidelines OTC monograph system — they’re classified as new molecular entities requiring NDA filing, which means an EU-approved formula cannot simply be re-labelled for US retail. If your brand is launching globally, we almost always flag this during the initial brief. Catching it at sample stage means a reformat. Catching it at launch means a recall risk.

For the most common use case we see — a brand launching first in Europe, UK, or Southeast Asia and building toward North America — our default recommendation is a Tinosorb S / Uvinul A Plus / ZnO combination. It covers broad-spectrum requirements, passes the EU critical wavelength threshold (≥370 nm per COLIPA protocol), and gives a workable sensory profile without heavy white cast. That’s not a universal answer. For a water-resistant reef-safe SPF 50+ targeting the US OTC channel, the architecture looks entirely different.

The Overlooked Variable — Lot-to-Lot Consistency and What It Does to SPF Outcomes #

Datasheet purity and production purity are not always the same number.

This is a point we raise with every brand that switches UV filter suppliers mid-project. We have seen SPF values shift by 4–6 SPF points across two otherwise identical batches when the only variable was a supplier change for Octinoxate — same INCI, same stated purity, different origin. The cis/trans isomer ratio at delivery is the likely driver, but we haven’t fully resolved whether it’s purely isomeric or partially linked to trace solvent residue in some lots. Our dataset covers 23 incoming lots over 18 months, which is enough to see the pattern but not enough to close the question.

Some brands treat UV filters as commodity inputs. In our experience, that approach works fine — until it doesn’t. The failure mode is quiet: SPF results just miss the label claim at in-vivo testing, with no obvious formulation change to blame.

What we now require for all UV filter suppliers at our facility is extended CoA data including isomeric purity (where applicable), residual solvent results, and a certificate of country of origin — the last one matters for EU import compliance under SCCS Scientific Opinion traceability recommendations. This is logged in our AVL (Approved Vendor List) gate review before a new supplier is released for production use.

Tinosorb M deserves a specific callout here. Because it’s supplied as an aqueous dispersion — typically 50% active — the active loading in your formula is always half the listed percentage unless you’re doing the recalculation. We’ve seen brief documents from brands specifying “10% Tinosorb M” without clarifying whether they mean the dispersion or the active. That ambiguity, resolved late, shifts the formula cost, viscosity, and water-phase balance. We flag it in every kickoff call that involves this filter.

Implementation Notes — What to Watch After You Lock the Filter System #

Locking a UV filter system in the lab is step one. Getting it to perform consistently at 200 kg pilot and then at full production scale is a different problem.

The two most common post-decision failure modes we see are oil-phase temperature management and UV filter dissolution sequence. Octinoxate and most organic liquid filters dissolve cleanly at 70–75°C oil-phase temperature. Push above 80°C for extended hold time and you start accelerating pre-formulation photodegradation in the melt phase — this isn’t theoretical, we’ve tracked it in our batch records. Tinosorb S needs a minimum of 20–25 minutes under agitation at 75°C for full dissolution into the oil phase. Rushing that step causes undissolved particulates that show up as white specks in the finished product.

For ZnO-based or Tinosorb M-based formulas, the critical step is dispersion quality before addition. Poorly dispersed mineral filters aggregate under shear at scale in ways that don’t appear in 1 kg lab batches. The relevant quality check at production scale is particle size distribution (D90 target ≤5 µm for cosmetic-grade nano ZnO) measured post-mixing, not just on the incoming material.

Our incoming inspection priorities for UV filter raw materials:

• Purity by HPLC (not UV spectroscopy alone — the two methods don’t always agree)
• Melting point or pour point vs. CoA spec — allowable variance ±2°C
• Water content (especially for Tinosorb S — above 0.3% moisture causes dissolution issues)
• Isomeric ratio where applicable (Octinoxate trans isomer target ≥98%)

Set a qualification milestone at pilot batch stage — don’t wait for full production to run your first in-vivo SPF test. We recommend collecting a finished pilot sample for ISO 24444 testing at the 200 kg stage, before committing to full production tooling or packaging procurement.

Clinical Reference — Performance Data Grounding the Filter Choices #

A 2022 split-face, double-blind RCT (n=52, 16 weeks, daily application) comparing a Tinosorb S / ZnO broad-spectrum formula (SPF 50+, PA+++) against an Octinoxate-only SPF 30 control reported a 38% greater reduction in UV-induced hyperpigmentation measured by colorimetry (ITA° change) in the broad-spectrum arm. The study, conducted under a European institutional review, also tracked photostability of the test formula at 8-week stability intervals — the Tinosorb S / ZnO arm showed less than 4% SPF degradation at 40°C/75% RH over 12 weeks, versus 11% SPF drop in the Octinoxate-only control.

We use this data point internally to argue for broad-spectrum filter combinations in any brief where hyperpigmentation prevention is a label claim — not because one study closes the argument, but because the photostability data mirrors what we see in our own accelerated stability results. The Octinoxate single-filter architecture has a structural weakness under real-world UV exposure that co-formulation addresses. Brands targeting Asian markets, where PA rating and anti-dark spot positioning are both commercially important, should factor this in from day one of the brief. Our sun protection and antioxidant category page has additional context on PA rating methodology and how filter combinations map to UVA-PF outcomes.

Formulation Notes for Brand Partners #

When you brief us on a sunscreen project, the first questions we ask cover market, format, and on-pack story — in that order. Market determines which filter list you’re working from and whether EU-only approvals create a problem for your distribution roadmap. Format (lotion, gel, stick, tint) changes the emulsion architecture, which changes which filters are even compatible. On-pack story — “mineral only,” “reef-safe,” “invisible finish” — sometimes directly contradicts the filter system that would give you the SPF you need. That’s the brief mistake we see most often: a brand locks the marketing story before consulting formulation, then discovers the filter system required to support the claim doesn’t deliver the aesthetics or the SPF value. We work through that reframe early.

On timeline: expect lab samples in 2–3 weeks from brief sign-off. Accelerated stability runs 4–8 weeks at 40°C/75% RH and 50°C. Twenty-four-month real-time stability is initiated concurrently with accelerated — don’t wait for accelerated to complete before starting real-time. In-vivo SPF testing (ISO 24444) adds 3–4 weeks depending on CRO scheduling. For US OTC submissions, budget an additional 8–12 weeks for SPF and water-resistance testing to FDA protocol requirements.

Frequently Asked Questions #

We want SPF 50+ with a mineral-only claim. Is that achievable without heavy white cast?
A: At SPF 50+ using ZnO only, you’re looking at a minimum effective load of around 20–22% uncoated ZnO — and yes, white cast is real at that level without dispersion engineering. With a surface-treated nano-grade ZnO at D50 ≤130 nm and a well-optimised dispersion protocol, we can hold white cast to acceptable levels for medium-to-deeper skin tones, but we’ll be direct: it’s harder than the ingredient suppliers make it sound.

Does using Tinosorb S in the formula block us from the US market?
A: Yes, for OTC sunscreen labelling in the US it does. Tinosorb S is not included in the current FDA Cosmetics Guidelines OTC monograph and has not completed the NDA review process. A formula using it can be sold in the US as a cosmetic without SPF claims, but you cannot carry the SPF label. If the US is a current or near-term market, we reformat from the start rather than plan a retrofit.

We’ve heard SPF values can drop during stability. How much should we expect?
A: For a well-designed broad-spectrum system, SPF drop over 12 weeks at 40°C/75% RH should be under 5%. In batches where we’ve used Octinoxate without a photostabiliser, we’ve seen drops as high as 11–14% over the same window — which can push an SPF 50 below the SPF 50+ threshold. The photostabiliser selection is not optional for Octinoxate-based formulas; it’s structural to the design.

What’s the MOQ for a custom SPF formula, and how long until we have a production-ready sample?
A: MOQ for custom SPF finished goods is typically 500 kg per SKU on our production line. From brief sign-off to a production-validated sample — meaning a sample that has passed accelerated stability and in-vivo SPF testing — plan for 14–18 weeks. That timeline assumes no major filter system reformulation mid-project and that in-vivo testing slots are pre-booked.

Should we specify the UV filter system ourselves, or leave that to the formulation team?
A: It depends on what you’re optimising for. If you have a specific regulatory requirement (EU only, no nano, reef-safe per Hawaii HRS 104) or a filter exclusion list from your brand standards, share that upfront and we’ll work within those constraints. If you don’t have strong filter preferences, leave the selection to us — specifying a filter system based on INCI name alone, without accounting for grade, supplier lot history, and emulsion compatibility, is where projects slow down. We’ve had briefs arrive with a full filter system pre-specified that required reformulation before it could pass our QC-F03 incoming inspection criteria.

---

Have a product concept in mind? Contact our formulation team to request a complimentary brief review.